Abiopharma

🔍 Wirk Shaheen (Executive)

Company: Movano Inc. (MOVE)

Report Date: 2026-01-09

Detailed Transactions and Holdings:

• Acquired 2,980 shares of Common Stock (Direct)
  Date: 2026-01-09 | Code: A | equity_swap_involved: false | shares_owned_after: 2,980.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,980 shares of Common Stock (Direct)
  Date: 2026-01-09 | Code: A | equity_swap_involved: false | shares_owned_after: 5,860.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The reported transaction involved the reporting person's receipt of a grant of 2,980 restricted stock units ("RSUs") under the Company's Omnibus Incentive Plan in lieu of cash directors' fees for the period January 1, 2026 to June 30, 2026.
• F2: The reported transaction involved the reporting person's receipt of a grant of 2,980 RSUs under the Company's Omnibus Incentive Plan for the period January 1, 2026 to June 30, 2026.